Lifeward (LFWD) Capital Expenditures (2015 - 2025)

Lifeward (LFWD) posted Capital Expenditures of $11000.0 for Q4 2025, up 120.0% sequentially from $5000.0 in Q1 2025.

Lifeward (LFWD) Capital Expenditures (2015 - 2025) Analysis & Trends

Lifeward has reported Capital Expenditures for 10 years, with the latest figure at $11000.0 in Q4 2025.

Quarterly Capital Expenditures changed N/A year-over-year to $11000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $11000.0 (up 120.0% YoY) and the FY2025 annual result came in at $16000.0, changed N/A from the prior year.
Capital Expenditures advanced to $11000.0 in Q4 2025 per LFWD's latest filing, from $5000.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $79000.0 in Q4 2023 and troughed at $2000.0 in Q2 2021.
A 4-year average of $15363.6 and a median of $9000.0 in 2021 frame the typical range for Capital Expenditures.
The sharpest annual moves came in 2022 and 2023: Capital Expenditures soared 650.0% in 2022, then tumbled 71.43% in 2023.
Over 4 years, Capital Expenditures stood at $19000.0 in 2021, then sank by 63.16% to $7000.0 in 2022, then jumped by 1028.57% to $79000.0 in 2023, then plunged by 86.08% to $11000.0 in 2025.
According to Business Quant data, Capital Expenditures over the past three periods registered $11000.0, $5000.0, and $79000.0 for Q4 2025, Q1 2025, and Q4 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	497.00 Mn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	202.00 Mn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	488.00 Mn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	195.00 Mn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	66.90 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	84.70 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	100.00 Mn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-74.39 Mn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	87.50 Mn
10	Lifeward	20.11 Mn	10.66 Mn	2.71 Mn	8,000.00

Download Data